Welcome to our dedicated page for Marex Group plc SEC filings (Ticker: MRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles U.S. Securities and Exchange Commission filings for Marex Group plc (NASDAQ: MRX), a diversified global financial services platform operating across energy, commodities and financial markets. As a foreign private issuer, Marex files an annual report on Form 20-F and periodic Form 6-K reports that furnish press releases and financial information to U.S. investors.
Recent Form 6-K filings include earnings-related disclosures, such as interim results, third quarter results and preliminary trading updates. These documents provide detail on revenue, adjusted profit before tax, segment performance across Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions, as well as information on net commission income, net trading income, net interest income and net physical commodities income. They also discuss non-IFRS measures, their definitions and reconciliations to the most comparable IFRS metrics.
Other 6-Ks relate to corporate actions and governance, including press releases about purchases of ordinary shares by the Chief Executive Officer and other directors and officers. These filings help investors track insider share dealings and understand how management and board members are building or adjusting their holdings in Marex.
Filings may also reference capital and ratings developments, such as senior debt issuances, Additional Tier 1 instruments and credit ratings from S&P Global Ratings for Marex Group and its U.S. subsidiary, Marex Capital Markets Inc. Together, these disclosures provide insight into the Group’s capital structure, funding and external credit assessment.
On Stock Titan, Marex’s SEC filings are updated as new documents are released on EDGAR. AI-powered tools can assist users by surfacing key points from lengthy filings, highlighting segment trends, explaining non-IFRS measures and drawing attention to notable items such as insider transactions and earnings commentary, helping readers navigate the technical language common in cross-border capital markets reporting.
Marex Group plc is offering Issuer Callable Contingent Income Barrier Notes linked to the worst performing of the EFA, RTY and NDX. The Notes have a $1,000 Principal Amount per Note, a Trade Date of April 24, 2026, an Original Issue Date of April 29, 2026, a Final Valuation Date of January 24, 2028 and a Maturity Date of January 27, 2028.
The Notes pay a quarterly Contingent Coupon of $34.75 per $1,000 (3.475% per quarter; 13.90% per annum) only if each Underlying is at or above its Coupon Trigger on the applicable Coupon Determination Date; otherwise no coupon is paid. The Coupon Trigger equals 70% of the Initial Value and the Barrier Value equals 65% of the Initial Value. Payment at maturity depends on the Reference Return of the Worst Performing Underlying with principal fully at risk if the Final Value is below the Barrier Value.
Marex Group plc President Simon Van Den Born reported selling a total of 13,265 Ordinary Shares on April 20, 2026 in two open-market transactions. One sale covered 12,624 shares at a weighted average price of $50.9165 per share, and the other covered 641 shares at a weighted average price of $51.7098 per share.
The transactions were carried out under a pre-arranged Rule 10b5-1 trading plan that he entered into on December 12, 2025. After these sales, each line item shows he continued to hold more than 1.5 million Ordinary Shares directly. His reported holdings include 383,741 shares underlying deferred bonus plan awards, each representing a contingent right to receive one Ordinary Share upon vesting and settlement.
Marex Group plc has issued $500,000,000 of 5.680% Senior Notes due 2031 in a completed public debt offering. The notes are senior unsecured obligations paying 5.680% interest in cash each April 21 and October 21, starting October 21, 2026, and maturing on April 21, 2031.
The company plans to use the net proceeds for working capital, to fund incremental growth and for other general corporate purposes. Marex may redeem the notes early at a make-whole price before March 21, 2031, or at 100% of principal plus accrued interest on or after that date. Holders can require a 101% repurchase plus accrued interest if a Change of Control Triggering Event occurs, and a future Bermuda holding company is expected to assume the notes as part of a proposed group reorganization.
Marex Group plc is offering $500,000,000 aggregate principal amount of 5.680% Senior Notes due April 21, 2031. The Notes pay interest semi-annually beginning October 21, 2026, and are a new issue for which Marex expects net proceeds to the issuer of approximately $498.0 million. Interest rates may adjust up or down based on credit rating changes by S&P and Fitch, and holders have a repurchase right at 101% of principal following a defined Change of Control Triggering Event. Marex may redeem the Notes in specified circumstances, including a Make-Whole Redemption, Par Call Redemption, Clean-up Call or upon certain tax changes. Marex also discloses a proposed redomiciliation to Bermuda, under which a new Bermuda parent would be expected to assume and be substituted as issuer of the Notes. Marex provided preliminary Q1 2026 ranges: revenue $667M–$697M and estimated profit after tax from continuing operations $103M–$111M.
Marex Group plc proposes an offering of senior notes due 2031 and files a preliminary prospectus supplement that also discloses recent corporate actions and preliminary Q1 2026 results. The supplement details a proposed redomiciliation to Bermuda, planned assumption of the notes by the new Bermuda parent, and preliminary unaudited Q1 2026 financial ranges.
The excerpt shows a $0.15 per-share dividend paid March 31, 2026; 71,930,870 ordinary shares outstanding as of the date of the supplement; and preliminary Q1 2026 estimated revenue of $667M–$697M with estimated adjusted profit before tax of $140M–$150M. The offering amount and interest rate are placeholder text in this excerpt.
Marex Group plc officer Paolo Tonucci reported selling 16,666 Ordinary Shares of the company on April 13, 2026 in open-market transactions. The sales occurred in three blocks of 6,760, 5,829 and 4,077 shares at weighted average prices of $50.6012, $51.5564 and $52.3578, respectively. These transactions were executed under a pre-arranged Rule 10b5-1 trading plan entered into on October 22, 2025, indicating they were scheduled in advance. Following the sales, Tonucci directly holds 1,363,357 Ordinary Shares, which include 286,871 shares underlying deferred bonus plan awards that each convert into one Ordinary Share upon vesting and settlement.
Marex Group plc has called its 2026 Annual General Meeting and parallel shareholder meetings to approve a redomiciliation of the group’s holding company from England and Wales to Bermuda via a court‑sanctioned scheme of arrangement. Each existing ordinary share will be exchanged on a one‑for‑one basis for a new Bermuda‑incorporated parent share, which will continue to trade on Nasdaq under the same symbol. Shareholders are also being asked to renew standard UK corporate authorities, including director re‑elections, auditor reappointment, authority to allot shares, a 10% pre‑emption disapplication, a share buyback mandate structured through Goldman Sachs, and a capped authority for political donations.
Marex Group plc filed a Form 13F reporting institutional holdings managed by the firm. The filing lists 901 Form 13F information-table entries with a total market value of $4,383,984,461. The report identifies 3 other included managers and is signed by Scott Linsley on 04-02-2026.
Marex Group plc President Simon Van Den Born reported open-market sales of a total of 13,264 ordinary shares. The trades occurred in two blocks at weighted average prices of $43.2683 and $43.9697 per share, executed under a pre-arranged Rule 10b5-1 plan entered into on December 12, 2025.
Following these transactions, he directly owns 1,522,229 ordinary shares, which include 383,741 shares underlying deferred bonus plan awards that may convert into ordinary shares upon vesting and settlement.
Marex Group plc executive Thomas Texier, Group Head of Clearing, reported open-market sales of company ordinary shares. On April 1, 2026, he sold 9,589 shares at a weighted average price of $43.2754 and 4,838 shares at a weighted average price of $43.9743 under a pre-arranged Rule 10b5-1 plan entered into on September 10, 2025.
Following these transactions, Texier directly holds 242,658 ordinary shares of Marex Group plc. This figure includes 192,348 shares underlying deferred bonus plan awards, each representing a contingent right to receive one ordinary share upon vesting and settlement.